Outcomes in stage I testicular seminoma: A population‐based study of 9193 patients
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Few studies have quantified temporal patterns of cause‐specific mortality in contemporary cohorts of men with early‐stage seminoma. Given that several management strategies can be applied in these patients, each resulting in excellent long‐term survival, it is important to evaluate associated long‐term sequelae. In particular, data describing long‐term risks of cardiovascular disease (CVD) are conflicting. METHODS: We identified 9193 men diagnosed with stage I seminoma (ages 15‐70 years) in the population‐based SEER registries (1973‐2001). We calculated survival estimates, standardized mortality ratios (SMRs), and adjusted hazard rates (AHRs). RESULTS: During 121,037 person‐years of follow‐up (median, 12.3 years), 915 deaths (SMR, 1.23; 95% CI, 1.16‐1.32) were reported, with significant excesses for suicide (n = 39; SMR, 1.45; 95% CI, 1.06‐1.98), infection (n = 58; SMR, 2.32; 95% CI, 1.80‐3.00), and second malignant neoplasms (SMNs; n = 291; SMR, 1.81; 95% CI, 1.61‐2.03), but not CVD (n = 201; SMR, 0.91; 95% CI, 0.80‐1.05). After radiotherapy (78% patients), CVD deaths were not increased (n = 158; SMR, 0.89; 95% CI, 0.76‐1.04), in contrast to SMN deaths (n = 246; SMR, 1.89; 95% CI, 1.67‐2.14). SMN mortality was higher among patients administered radiotherapy than among those not given radiotherapy (AHR, 1.36; 95% CI, 0.99‐1.88; P = .059), with a cumulative 15‐year risk of 2.64% (95% CI, 2.19‐3.16). Suicide, although rare, accounted for 1 in 230 deaths. CONCLUSIONS: Modern radiotherapy as applied in this large population‐based study is not associated with excess CVD mortality. Although increased all‐cause mortality exists, cumulative SMN risk is considerably smaller than reported in historical series, but additional follow‐up will be required to characterize long‐term trends. The increased risk of suicide, previously unreported in men with stage I seminoma, requires confirmation. Cancer 2013;119:2771–2777. © 2013 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamza, C. A., Stewart, S. L., & Willoughby, T. (2012) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.05.003 · Cited by 769
Incidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
Study of anxiety disorder and depression in long-term survivors of testicular cancer
Dahl, A. A., Haaland, C. F., Mykletun, A., Bremnes, R., Dahl, O., Klepp, O., Wist, E., & Fosså, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.061 · Cited by 176 · cited 1×
“3 years compared with age- and sex-matched controls.(23) Depression, anxiety,(24) and male sex(24) are established risk factors for suicide.”
Method
Cited by
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., Holland, J. C., Partridge, A. H., Bak, K., Somerfield, M. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4611 · Cited by 735
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C., Cathomas, R., Clarke, N., Cohn-Cedermark, G., Daugaard, G., Dieckmann, K.-P., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy217 · Cited by 326
Nass, S. J., Beaupin, L. K., Demark-Wahnefried, W., Fasciano, K., Ganz, P. A., Hayes-Lattin, B., Hudson, M. M., Nevidjon, B., Oeffinger, K. C., Rechis, R., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0265 · Cited by 311
Secondary malignant neoplasms in testicular cancer survivors
Curreri, S. A., Fung, C., & Beard, C. J. (2015) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.05.002 · Cited by 44
Self-citation
Metadata
- Authors
- Beard, C. J., Travis, L. B., Chen, M., Arvold, N. D., Nguyen, P. L., Martin, N. E., Kuban, D. A., Ng, A. K., & Hoffman, K. E.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2013-04-30
- Volume
- 119
- Issue
- 15
- Pages
- 2771-2777
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1638745316
- Cited by
- 85
- References
- 3
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.